Lutris Pharma
3 known investors
Find your way into Lutris Pharma
415 people in our graph share verified history with the Lutris Pharma team — schools, employers, funds. One of them is your warm intro.
Rebecca Jamesunlockedknows Sumant Ramachandra · together at The Wharton School (overlapped)
×8knows the team · via The Wharton School
knows the team · via Harvard Medical School - Massachusetts General Hospital
knows the team · via Rutgers University
knows the team · via Harvard Medical School and Massachusetts General Hospital
Lutris Pharma develops targeted skin protection treatments for cancer patients, combining clinicians and scientists with oncology expertise. The company focuses on pharmaceutical development in the oncology and dermatology space.
Founders & leadership
AR
Antoni Ribas, M.D., Ph.D.Founder and Chairman of the Board
SR
Sumant RamachandrainChief Executive Officer and Board DirectorSumant Ramachandra is CEO and Board Director of Lutris Pharma, a company developing targeted skin protection treatments for cancer patients. He holds an MD and PhD from Rutgers University, completed medical training at Massachusetts General Hospital under Harvard Medical School, and earned an MBA from Wharton Business School, with 25+ years of experience in biotechnology, pharmaceuticals, and medical technology.
JB
Jonathan BenjaminClinical Development Lead
OG
Ofir GoldbergerOperations and Strategy Lead
Investors · 3
In the news
Frequently asked questions
- What does Lutris Pharma do?
- Lutris Pharma develops targeted skin protection treatments for cancer patients, combining clinicians and scientists with oncology expertise. The company focuses on pharmaceutical development in the oncology and dermatology space.
- Who founded Lutris Pharma?
- Lutris Pharma was founded by Antoni Ribas, M.D., Ph.D..
- Who are Lutris Pharma's investors?
- Lutris Pharma's investors include aMoon, Peregrine Ventures, Pontifax Venture Capital.